Sp
Sprint Bio
Huddinge SEFounded 201430 employees
Private CapbiotechPrivateOncology
Platform: SBP-101
Market Cap
N/A
All Drugs
4
Clinical Trials
7
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| SPR-5098 | SPR-5098 | Phase 2 | 2 | CD20 | PV | ||
| SPR-7869 | SPR-7869 | Phase 1 | 1 | IL-17A | PTSD | ||
| Capiosocimab | SPR-1942 | Phase 1/2 | 2 | SMN2 | IPF | ||
| Daranesiran | SPR-7863 | Preclinical | 2 | IL-17A | CholangiocarcinomaEoE |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)